UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- UnitedHealth Group reported poor earnings on July 30, 2025.Sub-event
- UnitedHealth Group cut its profit forecast due to a surge in medical costs.Sub-event
UHG, Myriad Genetics, and NeoGenomics are linked regarding cancer diagnostics and healthcare sector weaknesses.1 source
Keep exploring
The entities involved
-
UnitedHealth Group
for-profit health care company
-
Myriad Genetics
American biotechnology company
-
NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
Coverage
Newest first; wire copies grouped- StockStoryWhy Is Myriad Genetics (MYGN) Stock Soaring Today Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 36.4% in the afternoon session after the company reported strong second-quarte